Events
Esperion, the Lipid Management Company announced that the company will participate in an analyst-led fireside chat with investors at the Needham & Company 18th Annual Healthcare Conference in New York, NY on Tuesday, April 9, 2019, at 11:20 a.m. Eastern Time.
In 1979, Evonik launched the thermoplastic elastomer polyether block amide (PEBA) under the brand name VESTAMID® E from its largest global production site in the Marl Chemical Park.
The American Association for Cancer Research (AACR) Annual Meeting is taking place in Atlanta. Here’s a look at just a few stories coming out of the meeting.
NOXXON Pharma N.V. announced the latest update of clinical results from the Phase 1/2 study of NOX-A12 in combination with Keytruda® in patients with microsatellite-stable, metastatic pancreatic and colorectal cancer in a poster presentation at the American Association for Cancer Research Annual Meeting.
The investigational therapeutic umbralisib, which targets the molecule PI3K- delta, was well tolerated and highly active in patients with relapsed/refractory marginal zone lymphoma, according to early results from the UNITY-NHL phase II clinical trial, which were presented at the AACR Annual Meeting 2019, March 29–April 3.
The American Association for Cancer Research (AACR) Annual Meeting is ongoing in Atlanta, with plenty of companies presenting interesting and cutting-edge science. Here’s a look at just a representative few.
During a presentation at the American Association for Cancer Research meeting over the weekend, Astellas touted new overall survival data for Xospata.
The Lead Discovery Center has won Dortmund’s Business Prize, awarded yearly by the Wirtschaftsförderung and the Sparkasse Dortmund.
Microbix Biosystems Inc., an innovator of biological products and technologies, announces the voting results from the Annual Meeting of Shareholders which was held on March 27, 2019.
Orion Biotechnology Canada Ltd. announced that it will be presenting data on the potency of OB-002, their CCR5 antagonist currently in development for HIV prevention and oncology indications, at the 10th IAS HIV Science Meeting that will be held in Mexico City in July 2019.
PRESS RELEASES